Aspire Biopharma Holdings, Inc. (ASBP) Restructuring Costs (2026)
Aspire Biopharma Holdings (ASBP) reported Restructuring Costs of $229,418 for Q2 2026.
Powered by 
Analysis
Aspire Biopharma Holdings, Inc. (ASBP) Restructuring Costs (2026) Analysis & Trends
Peer Set
Peer Comparison
API Access
Aspire Biopharma Holdings, Inc. Restructuring Costs API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=restructuring-costs&ticker=ASBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "restructuring-costs", "ticker": "ASBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=restructuring-costs&ticker=ASBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();